Skip Navigation

Dedicates to corporate sustainability, Lotus receives Asia Responsible Enterprise Awards

24 September 2020

Lotus Pharmaceutical Co., Ltd (“Lotus” or “the Company”, Taiwan TWSE ticker: 1795) today announced that it received the Asia Responsible Enterprise Awards (AREA) by Enterprise Asia among over 200 submissions across 19 countries in Asia for the Company’s great efforts on global environmental protection and corporate sustainability. This is the second time that Lotus recognized by Enterprise Asia. Lotus obtained the Asia Pacific Enterprise Award (APEA) from Enterprise Asia last year for being one of the 8 best companies honoring innovation and sustainability.

The Summit hosted by Enterprise Asia themed “Purpose Before Profits: An Equilibrium World”, convened over 600 corporate social responsibility and sustainability leaders and practitioners representing 19 countries in Asia.

Petar Vazharov, Chief Executive Officer of Lotus, indicated, “Affordability and accessibility of oncology treatment for patients are persistent targets to medicine industry around the world. To help the increasing popularity of oncology diseases, Lotus is diligent in making efforts to provide high-quality and affordable drugs for patients in the world by leveraging its leading oncology R&D capabilities and portfolio pipeline. Moreover, Lotus is providing its products and solutions globally through Alvogen’s well-established and highly-connected marketing network worldwide. To bring people better and heathier life, Lotus will continue to provide high-value and affordable treatment choices for global patients.”

By collaborating various corporate resources, Lotus proactively follows the United Nation's "Sustainable Development Goals (SDGs)- Health and Wellbeing of SDG03, Employment and Economic Growth of SDG08, and Reduces Inequality of SDG10" guidance, to gradually reduce patients’ medical expenses burden, treatment delays caused by personal financial worries, and other social costs. These efforts awarded Lotus the Asia Responsible Enterprise Awards of 2020, which is also the only awarded pharmaceutical company in Taiwan this year.

In addition to the recognition from the AREA, which reaffirms the Company’s strong commitment in social responsibility, Lotus was also recognized by public for excellent operational performance this year. Lotus is not only ranked among the “Top 2000 Manufacturing Companies” in Taiwan by CommonWealth Magazine in May, but also ranked again as No.3 in “Top 10 Fast-growing Companies of Revenue” category among the “Top 100 Fast Growing Companies” in Taiwan this August.